Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/17/2008 First Published: 5/28/2004


1.		Phase III Randomized Study of Cisplatin and Radiotherapy With or Without Hyperthermia in Patients With Locally Advanced Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				DUMC-4516-04-2R1ER DUMC-G030263, DUMC-4516031R0, NCT00085631

Last Modified: 10/10/2008 First Published: 11/25/2005


2.		Phase III Randomized Study of Cisplatin and Radiotherapy With Versus Without Tirapazamine in Patients With Stage IB, IIA, IIB, IIIB, or IVA Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				GOG-0219 GOG-0219, CAN-NCIC-GOG-0219, NCT00262821


3.		Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				UCI 03-33 NCT00257816


4.		Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				05-0702 CA225243, NCT00292955

Last Modified: 10/8/2008 First Published: 8/18/2006


5.		Phase II Study of Bevacizumab, Definitive Radiotherapy, and Cisplatin in Patients With Previously Untreated Locally Advanced Cervical Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				NCI				RTOG-0417 RTOG-0417, NCT00369122

Last Modified: 5/22/2008 First Published: 5/4/2007


6.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Last Modified: 4/24/2008 First Published: 11/12/2007


7.		Phase II Study of Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 in Assessing Tumor Hypoxia in Patients Undergoing Therapy for Newly Diagnosed Stage III or IV Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Active				18 and over				NCI				UW-6143 UW IRB# 6143, 7958, NCT00559377


8.		Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06-1098 GSK 107278, NCT00548418


9.		Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				AVF3963s NCT00600210

Last Modified: 9/19/2008 First Published: 6/3/2008


10.		Phase II Study of Pemetrexed Disodium and Cisplatin in Patients With Advanced, Persistent, or Recurrent Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				NCI				GOG-0076GG GOG-0076GG, NCT00691301

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute